Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection
Samer A. Naffouje, Arvind Sabesan, Dae Won Kim, Estrella Carballido, Jessica Frakes, Pamela Hodul, Jason W. Denbo, Mokenge Malafa, Jason Fleming, Sarah Hoffe
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection'. Together they form a unique fingerprint.